Zepp Health (NYSE:ZEPP) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Zepp Health (NYSE:ZEPP) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.

Separately, Fundamental Research set a $56.28 target price on Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $56.28.

Zepp Health Stock Up 5.4%

Zepp Health stock opened at $5.42 on Friday. The stock has a market cap of $79.57 million, a PE ratio of -2.15 and a beta of 1.83. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.88 and a quick ratio of 0.67. The stock’s fifty day moving average is $6.54 and its two-hundred day moving average is $14.78. Zepp Health has a 1-year low of $3.85 and a 1-year high of $61.85.

Insider Activity at Zepp Health

In related news, CFO Cheng Deng sold 9,836 shares of Zepp Health stock in a transaction on Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the sale, the chief financial officer directly owned 114,539 shares in the company, valued at $528,024.79. This trade represents a 7.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Zepp Health

Large investors have recently bought and sold shares of the stock. UBS Group AG grew its holdings in shares of Zepp Health by 16,412.0% during the third quarter. UBS Group AG now owns 181,302 shares of the company’s stock worth $8,300,000 after purchasing an additional 180,204 shares during the last quarter. Harvest Fund Management Co. Ltd purchased a new stake in shares of Zepp Health in the 3rd quarter valued at about $1,895,000. Lighthouse Investment Partners LLC purchased a new stake in shares of Zepp Health in the 3rd quarter valued at about $2,070,000. Millennium Management LLC acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $11,265,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in shares of Zepp Health in the 3rd quarter valued at about $43,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.